Patent details

EP2393485 Title: BILAYER TABLETS COMPRISING ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR

Basic Information

Publication number:
EP2393485
PCT Application Number:
PCT/US/2010/023226
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP107037665
PCT Publication Number:
WO/2010/091197
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BILAYER TABLETS COMPRISING ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR
French Title of Invention:
COMPRIMÉ BICOUCHE CONTENANT DE L'ELVITEGRAVIR, DU COBICISTAT, DE L'EMTRICITABINE ET DU TENOFOVIR
German Title of Invention:
ZWEISCHICHTIGE TABLETTE ENTHALTEND ELVITEGRAVIR, COBICISTAT, EMTRICITABINE UND TENOFOVIR
SPC Number:

Dates

Filing date:
04/02/2010
Grant date:
29/07/2015
EP Publication Date:
29/07/2015
PCT Publication Date:
12/08/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/12/2011
EP B1 Publication Date:
29/07/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
04/02/2030
Renunciation date:
Revocation date:
23/01/2017
Annulment date:

Owner

From:
04/02/2010
 
 

Name:
Gilead Sciences Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
15/09/2015
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
OLIYAI Reza
Address:
United States (US)

2

Name:
KOZIARA Joanna, M.
Address:
United States (US)

3

Name:
MENNING Mark, M.
Address:
United States (US)

Priority

1

Priority Number:
150655 P
Priority Date:
06/02/2009
Priority Country:
United States (US)

2

Priority Number:
150652 P
Priority Date:
06/02/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/20;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2017/03
Publication date:
21/07/2017
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
201722
Publication date:
31/05/2017
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
25/02/2016
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56